A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
dc.contributor.author | Freedman, Gary M. | en_US |
dc.contributor.author | Zalupski, Mark M. | en_US |
dc.contributor.author | Small, William | en_US |
dc.contributor.author | Mulcahy, Mary F. | en_US |
dc.contributor.author | Hoffman, John P. | en_US |
dc.contributor.author | McGinn, Cornelius J. | en_US |
dc.contributor.author | Colletti, Lisa M. | en_US |
dc.contributor.author | Wayne, Jeffrey D. | en_US |
dc.contributor.author | Attaluri, Vikram | en_US |
dc.contributor.author | Kinsella, Timothy J. | en_US |
dc.contributor.author | Philip, Philip A. | en_US |
dc.contributor.author | Talamonti, Mark S. | en_US |
dc.date.accessioned | 2006-09-08T19:13:44Z | |
dc.date.available | 2006-09-08T19:13:44Z | |
dc.date.issued | 2006-02 | en_US |
dc.identifier.citation | Talamonti, Mark S.; Small, William; Mulcahy, Mary F.; Wayne, Jeffrey D.; Attaluri, Vikram; Colletti, Lisa M.; Zalupski, Mark M.; Hoffman, John P.; Freedman, Gary M.; Kinsella, Timothy J.; Philip, Philip A.; McGinn, Cornelius J.; (2006). "A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma." Annals of Surgical Oncology 13(2): 150-158. <http://hdl.handle.net/2027.42/41411> | en_US |
dc.identifier.issn | 1534-4681 | en_US |
dc.identifier.issn | 1068-9265 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41411 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16418882&dopt=citation | en_US |
dc.description.abstract | We report the results of a multi-institutional phase II trial that used preoperative full-dose gemcitabine and radiotherapy for patients with potentially resectable pancreatic carcinoma. | en_US |
dc.format.extent | 304717 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; The Society of Surgical Oncology, Inc. | en_US |
dc.subject.other | Surgery | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Neoadjuvant Therapy | en_US |
dc.subject.other | Surgical Oncology | en_US |
dc.subject.other | Pancreas Cancer | en_US |
dc.subject.other | Gemcitabine and Radiotherapy | en_US |
dc.subject.other | Pancreas Surgery | en_US |
dc.title | A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Gastrointestinal Surgery, University of Michigan Health System, 2922 G Taubman-0331, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109 | en_US |
dc.contributor.affiliationum | Hematology Oncology, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109 | en_US |
dc.contributor.affiliationother | Department of Radiation Oncology, University of South Maine, 22 Bramhall Street, Portland, Maine, 04102 | en_US |
dc.contributor.affiliationother | Division of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611 | en_US |
dc.contributor.affiliationother | Division of Radiation Oncology, Feinberg School of Medicine, Northwestern University, 251 E. Huron, LC-178, Chicago, Illinois, 60611 | en_US |
dc.contributor.affiliationother | Division of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611 | en_US |
dc.contributor.affiliationother | Division of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611 | en_US |
dc.contributor.affiliationother | Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania, 19111 | en_US |
dc.contributor.affiliationother | Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania, 19111 | en_US |
dc.contributor.affiliationother | Division of Hematology Oncology, Wayne State University, 3990 John R. Street, Detroit, Michigan, 48201-2018 | en_US |
dc.contributor.affiliationother | Department of Radiation Oncology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio, 44106-6068 | en_US |
dc.contributor.affiliationother | Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, 675 N. St. Clair, Galter 21-100, Chicago, Illinois, 60611 | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 16418882 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41411/1/10434_2006_Article_9435.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1245/ASO.2006.03.039 | en_US |
dc.identifier.source | Annals of Surgical Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.